Medication info
Richstar Tablet 40/5 mg

Richstar Tablet 40/5 mg

Prescription medicationOral
Ingredient · strength
Telmisartan Powder 23.9%›167.36mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Punglim Pharmaceutical Co., Ltd.
Appearance
It is a biconvex oval-shaped double tablet that is white and light gray.
Packaging
30 tablets (10 tablets/PTP × 3)
Approval status
Active

MFDS item code 201700544 · Approved 2017.01.31 · Insurance code 649001660

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
Child dose
Pediatric patients aged 18 years or younger: This medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Punglim Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication can be used effectively to control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with telmisartan or amlodipine alone. This helps reduce the risk of cardiovascular complications associated with high blood pressure and improves the patient's health status. This medication contributes to an overall improvement in the patient's quality of life by stabilizing blood pressure.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before starting this medicine. However, direct switching to this medicine may be considered if blood pressure is not controlled with an individual component, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase it gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.

Child dose

Pediatric patients aged 18 years or younger: This medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication should not be used during pregnancy, especially during the second and third trimesters, as it can pose a serious risk to the fetus. It should not be administered to individuals with allergies to this medication’s active ingredients or similar drugs, as well as to women who are pregnant or breastfeeding, and to patients with certain liver or heart diseases. Patients with liver or gastrointestinal diseases, reduced kidney function, elderly patients, and those with specific heart valve diseases should use this medication with caution. Side effects such as dizziness or edema may commonly occur during treatment, and serious side effects may rarely develop; therefore, any unusual symptoms should be promptly discussed with healthcare professionals. As this medication can cause a sudden drop in blood pressure, if hypotension is suspected, the patient should be laid down and receive intravenous therapy if necessary, and the dosage should be adjusted according to medical guidance when initiating treatment. This medication can increase potassium levels; hence, blood potassium levels should be regularly monitored when taken with potassium supplements or medications containing potassium. Patients with diminished kidney function should have their kidney function and electrolyte levels routinely checked before and after taking this medication. This medication can interact with other antihypertensive drugs and specific medications, so it is essential to inform healthcare professionals of any other medications being taken. Dizziness or drowsiness may occur when driving or operating dangerous machinery, so caution should be exercised. In cases of overdose, severe hypotension or heart-related issues may occur; therefore, adherence to the prescribed dosage is crucial, and immediate contact with healthcare institutions is necessary in the case of an overdose. This medication is not recommended for children as its safety and efficacy have not been sufficiently established in this population. When storing, keep it out of reach of children, take it immediately after opening, and do not transfer it to another container.

Side effects

  • Dizziness
  • peripheral edema
  • syncope
  • upper respiratory tract infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
Show 92 more
  • thrombocytopenia
  • eosinophilia
  • leukopenia
  • hypersensitivity
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • hyperglycemia
  • depression
  • insomnia
  • anxiety
  • confusion
  • drowsiness
  • headache
  • migraine
  • paresthesia
  • hypoesthesia
  • taste disturbances
  • tremor
  • extrapyramidal disorders
  • hypertonia
  • visual impairment
  • vertigo
  • tinnitus
  • palpitations
  • bradycardia
  • tachycardia
  • myocardial infarction
  • ventricular tachycardia
  • arrhythmia
  • atrial fibrillation
  • flushing
  • hypotension
  • orthostatic hypotension
  • vasculitis
  • cough
  • dyspnea
  • rhinitis
  • change in bowel habits
  • diarrhea
  • constipation
  • abdominal pain
  • dyspepsia
  • nausea
  • vomiting
  • dry mouth
  • gingival hyperplasia
  • abdominal discomfort
  • pancreatitis
  • gastritis
  • eczema
  • erythema
  • rash
  • angioedema
  • toxic skin eruption
  • drug rash
  • urticaria
  • sweating
  • alopecia
  • purpura
  • skin discoloration
  • hyperuricemia
  • liver function abnormalities
  • liver disorders
  • hepatitis
  • jaundice
  • increased liver enzymes
  • joint swelling
  • muscle cramps
  • arthralgia
  • myalgia
  • low back pain
  • limb pain
  • tendon pain
  • renal dysfunction
  • urinary disorders
  • frequency of urination
  • nocturia
  • erectile dysfunction
  • gynecomastia
  • edema
  • weakness
  • fatigue
  • chest pain
  • malaise
  • influenza-like illness
  • increased liver enzymes
  • increased blood creatinine
  • weight gain
  • weight loss
  • increased blood uric acid

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light; therefore, it should be stored in a container that does not allow light to enter. Additionally, it is crucial to maintain a room temperature between 1 and 30 degrees Celsius when storing the medication to ensure its effectiveness is safely preserved.

Appearance and packaging

Appearance

It is a biconvex oval-shaped double tablet that is white and light gray.

Package unit

30 tablets (10 tablets/PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.